Nordea Investment Management AB Has $5.60 Million Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Nordea Investment Management AB trimmed its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 14.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 490,280 shares of the medical instruments supplier’s stock after selling 80,186 shares during the period. Nordea Investment Management AB owned about 0.25% of DENTSPLY SIRONA worth $5,604,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of XRAY. AQR Capital Management LLC increased its position in DENTSPLY SIRONA by 109.8% in the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after purchasing an additional 6,970,086 shares during the last quarter. Armistice Capital LLC lifted its holdings in shares of DENTSPLY SIRONA by 1,044.0% during the 3rd quarter. Armistice Capital LLC now owns 5,736,000 shares of the medical instruments supplier’s stock valued at $72,790,000 after buying an additional 5,234,587 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its stake in shares of DENTSPLY SIRONA by 662.0% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 4,608,341 shares of the medical instruments supplier’s stock valued at $58,480,000 after buying an additional 4,003,606 shares in the last quarter. Norges Bank bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at approximately $39,700,000. Finally, Goldman Sachs Group Inc. increased its holdings in DENTSPLY SIRONA by 827.3% in the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock worth $36,378,000 after buying an additional 2,172,343 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director James D. Forbes purchased 5,000 shares of the firm’s stock in a transaction on Monday, March 9th. The stock was bought at an average cost of $12.48 per share, for a total transaction of $62,400.00. Following the completion of the acquisition, the director directly owned 10,000 shares of the company’s stock, valued at approximately $124,800. The trade was a 100.00% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gregory T. Lucier purchased 27,555 shares of the stock in a transaction dated Monday, March 2nd. The stock was acquired at an average cost of $14.24 per share, for a total transaction of $392,383.20. Following the completion of the transaction, the director owned 27,555 shares of the company’s stock, valued at $392,383.20. The trade was a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 70,000 shares of company stock worth $956,437 in the last quarter. Insiders own 0.50% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Barrington Research raised their price objective on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a research report on Monday, March 2nd. Wells Fargo & Company increased their price target on shares of DENTSPLY SIRONA from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. Barclays began coverage on shares of DENTSPLY SIRONA in a report on Monday, December 8th. They set an “underweight” rating and a $12.00 price target on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, January 21st. Finally, UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating for the company in a report on Tuesday, February 3rd. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $14.42.

DENTSPLY SIRONA Stock Down 0.2%

Shares of DENTSPLY SIRONA stock opened at $11.66 on Friday. DENTSPLY SIRONA Inc. has a 12-month low of $9.85 and a 12-month high of $17.18. The company has a quick ratio of 1.03, a current ratio of 1.51 and a debt-to-equity ratio of 1.50. The stock has a 50 day moving average price of $12.58 and a two-hundred day moving average price of $12.24. The stock has a market capitalization of $2.33 billion, a P/E ratio of -3.89, a PEG ratio of 1.37 and a beta of 0.97.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). DENTSPLY SIRONA had a negative net margin of 16.25% and a positive return on equity of 18.85%. The firm had revenue of $961.00 million during the quarter, compared to the consensus estimate of $926.40 million. During the same period in the prior year, the business earned $0.26 EPS. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.